Selecta Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Cartesian Therapeutics

02/03/2023 14:35

* Selecta Biosciences Inc  SELB.OQ  reported quarterly
adjusted
earnings of 4 cents​​ per share for the quarter ended in
December. The mean expectation of seven analysts for the quarter
was for a loss of 7 cents per share.
    * Revenue fell 43.9% to $16.80 million from a year ago;
analysts
expected $11.68 million. 
    * Selecta Biosciences Inc's reported EPS for the quarter was
4
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Selecta Biosciences Inc shares had risen by 41.6% this
quarter.
    * The company reported quarterly net income of $5.89
million.
    * Wall Street's median 12-month price target for Selecta
Biosciences Inc is $7.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 2
at 02:35 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.07          0.04           Beat
 Sep. 30 2022      -0.01          -0.05          Missed
 Jun. 30 2022      -0.08          0.06           Beat
 Mar. 31 2022      -0.11          0.23           Beat